$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 17, 2025)
$272.34K
Market Cap
-
P/E Ratio
-28.75
EPS
$27.00
52 Week High
$2.73
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Processa Pharmaceuticals, Inc. (PCSA) is a clinical-stage biopharmaceutical company headquartered in Hanover, Maryland, dedicated to developing innovative therapies for unmet medical needs. The company boasts a diverse portfolio of proprietary drug candidates currently progressing through rigorous clinical trials, specifically targeting significant health challenges in underserved therapeutic areas. With a strong commitment to improving patient outcomes and enhancing quality of life, Processa Pharmaceuticals is strategically positioned to be a compelling investment opportunity within the evolving healthcare sector.
LPTX
NVDA
IRBT
TSLA
CGC
PLUG
WOK
AVGO
GRAB
WBD
ASST
RXRX
SNAP
RZLV
PFE
F
AAL
PLTD
INTC
BITF
ADAP
NFLX
PLTR
ORCL
SOFI
MARA
LAZR
CIFR
WULF
GOOGL
BYND
MU
DNN
ADTX
T
PCSA
IVP
KVUE
HOOD
RIG
BAC
RGTI
IREN
AMD
HPE
VHAI
KDLY
TLRY
ITUB
QBTS
APLD
BTBT
GOOG
NIO
CPNG
VICI
UBER
CMG
CLSK
CSCO
AG
VALE
SMCI
MSFT
PBR
AMC
HBAN
RKLB
QS
PCG
LPTX
NVDA
IRBT
TSLA
CGC
PLUG
WOK
AVGO
GRAB
WBD
ASST
RXRX
SNAP
RZLV
PFE
F
AAL
PLTD
INTC
BITF
ADAP
NFLX
PLTR
ORCL
SOFI
MARA
LAZR
CIFR
WULF
GOOGL
BYND
MU
DNN
ADTX
T
PCSA
IVP
KVUE
HOOD
RIG
BAC
RGTI
IREN
AMD
HPE
VHAI
KDLY
TLRY
ITUB
QBTS
APLD
BTBT
GOOG
NIO
CPNG
VICI
UBER
CMG
CLSK
CSCO
AG
VALE
SMCI
MSFT
PBR
AMC
HBAN
RKLB
QS
PCG